Egerkingen, Switzerland

Boris Mathys

USPTO Granted Patents = 34 


 

Average Co-Inventor Count = 6.6

ph-index = 11

Forward Citations = 346(Granted Patents)


Location History:

  • CH-4622 Egerkingen, CH (2010)
  • Prattein, CH (2012 - 2013)
  • Pratteln, CH (2011 - 2014)
  • Egerkingen, CH (2004 - 2015)
  • Allschwil, CH (2014 - 2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Boris Mathys

Introduction

Boris Mathys, based in Egerkingen, Switzerland, is a renowned inventor with an impressive portfolio of 34 patents. His work primarily focuses on pharmaceutical compositions and derivatives that aim to address health challenges associated with immune system disorders.

Latest Patents

Among his recent innovations, Boris has developed two notable patents. The first is dedicated to 2-methoxy-pyridin-4-yl derivatives, which pertains to specific pyridine derivatives of Formula (I). The second is focused on thiazolidin-4-one derivatives, relating to pharmaceutical compositions that contain these derivatives, aimed at preventing or treating disorders linked to an activated immune system. These compounds are particularly noteworthy for their potential as immunosuppressive agents, marking a significant step forward in the development of new therapeutics.

Career Highlights

Boris Mathys has made substantial contributions during his tenure at Actelion Pharmaceuticals Ltd. His expertise in developing pharmaceutical solutions has greatly impacted the field, showcasing his ability to innovate and create valuable medicinal products.

Collaborations

Throughout his career, Boris has collaborated with esteemed colleagues such as Claus Mueller and Oliver Nayler. These partnerships have fostered a rich environment for creativity and advancement in pharmaceutical research, significantly enhancing the quality and scope of his inventions.

Conclusion

Boris Mathys remains a pivotal figure in the realm of pharmaceutical innovations. His 34 patents underscore his commitment to addressing critical health issues, while his collaborations and career experiences highlight the collaborative nature of scientific advancement. As he continues to innovate, the implications of his work will undoubtedly contribute to future breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…